Malta - anglès - Medicines Authority

mylan s.a.s. 117 allee des parcs, 69800 saint priest, france - fluvastatin - capsule - fluvastatin 20 mg - lipid modifying agents

Malta - anglès - Medicines Authority

novartis pharmaceuticals uk limited - fluvastatin 20 mg - hard capsule

Malta - anglès - Medicines Authority

novartis pharmaceuticals uk limited - fluvastatin 40 mg - hard capsule

Malta - anglès - Medicines Authority

novartis pharmaceuticals uk limited - fluvastatin 80 mg - prolonged-release tablet

Malta - anglès - Medicines Authority

alphafarma limited - fluvastatin 80 mg - prolonged-release tablet

Malta - anglès - Medicines Authority

neofarma pharmaceuticals limited 42-46, mill street, qormi, qrm 3105, malta - fluvastatin sodium - prolonged-release tablet - fluvastatin sodium 80 mg - lipid modifying agents

Malta - anglès - Medicines Authority

actavis group ptc ehf revkjavikurvegi 76-78, 220 hafnarfjordur, iceland - fluvastatin - hard capsule - fluvastatin 20 mg - lipid modifying agents

Malta - anglès - Medicines Authority

actavis group ptc ehf revkjavikurvegi 76-78, 220 hafnarfjordur, iceland - fluvastatin - hard capsule - fluvastatin 40 mg - lipid modifying agents

Malta - anglès - Medicines Authority

actavis group ptc ehf revkjavikurvegi 76-78, 220 hafnarfjordur, iceland - fluvastatin - prolonged-release tablet - fluvastatin 80 mg - lipid modifying agents

Irlanda - anglès - HPRA (Health Products Regulatory Authority)

imed healthcare ltd. - fluvastatin - prolonged-release tablet - 80 milligram(s) - fluvastatin - coa reductase inhibitors - dyslipidaemia treatment of adults with primary hypercholesterolemia or mixed dyslipidemia, as an adjunct to diet, when response to diet and other non-pharmacological treatments (e.g. exercise, weight reduction) is inadequate. secondary prevention in coronary heart disease secondary prevention of major adverse cardiac events in adultswith coronary heart disease after percutaneous coronary interventions